News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,638 Results
Type
Article (87351)
Company Profile (759)
Press Release (771502)
Multimedia
Podcasts (168)
Webinars (28)
Section
Business (233021)
Career Advice (4137)
Deals (39786)
Drug Delivery (134)
Drug Development (91232)
Employer Resources (202)
FDA (18270)
Job Trends (17394)
News (397312)
Policy (39918)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (141)
Alzheimer's disease (1670)
Antibody-drug conjugate (ADC) (219)
Approvals (18277)
Artificial intelligence (474)
Autoimmune disease (65)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (50)
Breast cancer (468)
Cancer (3729)
Cardiovascular disease (330)
Career advice (3552)
Career pathing (37)
CAR-T (237)
CDC (53)
Cell therapy (655)
Cervical cancer (32)
Clinical research (75175)
Collaboration (1342)
Company closure (4)
Compensation (916)
Complete response letters (59)
COVID-19 (2947)
CRISPR (80)
C-suite (553)
Cystic fibrosis (132)
Data (4101)
Decentralized trials (2)
Denatured (60)
Depression (108)
Diabetes (443)
Diagnostics (7075)
Digital health (35)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (178)
Drug shortages (36)
Duchenne muscular dystrophy (195)
Earnings (98702)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132654)
Executive appointments (973)
FDA (20633)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1206)
Gene editing (168)
Generative AI (45)
Gene therapy (520)
GLP-1 (1007)
Government (5371)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (36)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3177)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (180)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (634)
Leadership (31)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (532)
Lymphoma (256)
Machine learning (27)
Management (66)
Manufacturing (610)
MASH (130)
Medical device (14852)
Medtech (14873)
Mergers & acquisitions (22714)
Metabolic disorders (1125)
Multiple sclerosis (133)
NASH (23)
Neurodegenerative disease (216)
Neuropsychiatric disorders (59)
Neuroscience (2661)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (56)
Obesity (551)
Opinion (308)
Ovarian cancer (122)
Pain (160)
Pancreatic cancer (163)
Parkinson's disease (232)
Partnered (28)
Patents (402)
Patient recruitment (295)
Peanut (57)
People (66173)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23173)
Phase II (32646)
Phase III (24562)
Pipeline (2602)
Policy (288)
Postmarket research (3554)
Preclinical (10461)
Press Release (72)
Prostate cancer (187)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (644)
Real estate (7420)
Recruiting (78)
Regulatory (27884)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (13)
RNA editing (15)
RSV (69)
Schizophrenia (130)
Series A (200)
Series B (148)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (89)
The Weekly (106)
Vaccines (1027)
Venture capital (66)
Weight loss (387)
Women's health (57)
Worklife (21)
Date
Today (97)
Last 7 days (596)
Last 30 days (2310)
Last 365 days (33662)
2025 (25177)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50880)
Australia (8939)
California (9187)
Canada (2795)
China (863)
Colorado (391)
Connecticut (410)
Delaware (253)
Europe (116915)
Florida (1351)
Georgia (308)
Hawaii (3)
Idaho (67)
Illinois (800)
India (47)
Indiana (447)
Iowa (19)
Japan (300)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1244)
Massachusetts (6924)
Michigan (307)
Minnesota (552)
Mississippi (4)
Missouri (115)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2547)
New Mexico (32)
New York (2511)
North Carolina (1388)
North Dakota (10)
Northern California (4113)
Ohio (286)
Oklahoma (20)
Oregon (50)
Pennsylvania (1919)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3511)
Tennessee (148)
Texas (1439)
United States (34062)
Utah (272)
Virginia (243)
Washington D.C. (82)
Washington State (793)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,638 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
October 6, 2025
·
5 min read
Press Releases
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease
October 6, 2025
·
23 min read
Press Releases
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
October 6, 2025
·
11 min read
Press Releases
ESSA Securityholders Approve Acquisition by XenoTherapeutics
October 6, 2025
·
8 min read
Press Releases
Albert Einstein College of Medicine Awarded $18 Million NIH Grant to Improve Treatment for Serious Mental Illness
October 6, 2025
·
5 min read
Press Releases
Sonoma Biotherapeutics Congratulates Fred Ramsdell, PhD, Co-Founder and Scientific Advisory Board Chair, on Receiving the 2025 Nobel Prize in Physiology or Medicine...
October 6, 2025
·
3 min read
Press Releases
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - October 6, 2025
October 6, 2025
·
3 min read
Press Releases
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
October 6, 2025
·
11 min read
Press Releases
Vertex to Announce Third Quarter 2025 Financial Results on November 3rd
October 6, 2025
·
1 min read
Press Releases
Johnson & Johnson to Participate in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference
October 6, 2025
·
1 min read
1 of 85,964
Next
